Zura Bio Limited Class A Ordinary Shares (ZURA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $119.44M
Last updated: Nov 17, 2026 at 11:06 AM ET
Zura Bio Limited Class A Ordinary Shares (ZURA) Competitors
The companies most similar to Zura Bio Limited Class A Ordinary Shares are TuHURA Biosciences (HURA), LENZ Therapeutics (LENZ) and Rallybio (RLYB). By market cap, Zura Bio Limited Class A Ordinary Shares ranks 7th of the 13 companies on this page; Zentalis Pharmaceuticals Llc (ZNTL) is the largest at $167.05M.
Peer Comparison
ZURA's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Zura Bio Limited Class A Ordinary Shares (ZURA) | $119.44M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| TuHURA Biosciences Inc (HURA) | $88.58M | N/A | N/A | 0.0% | -81.8% | 0.0% | 0.00% |
| LENZ Therapeutics Inc (LENZ) | $129.77M | N/A | 9.7x | 0.0% | N/A | -72.9% | 0.00% |
| Rallybio Corp (RLYB) | $88.03M | N/A | 203.1x | 6177.0% | N/A | 0.0% | 0.00% |
| Zentalis Pharmaceuticals Llc (ZNTL) | $167.05M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Unicycive Therapeutics Inc (UNCY) | $97.25M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tiziana Life Sciences Ltd (TLSA) | $72.53M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Kazia Therapeutics Ltd ADR (KZIA) | $75.65M | N/A | N/A | 0.0% | N/A | 312.4% | 0.00% |
| Sutro Biopharma (STRO) | $163.03M | N/A | 3.4x | 0.0% | N/A | -6.1% | 0.00% |
| Upstream Bio, Inc. (UPB) | $152.38M | N/A | 41.0x | 0.0% | N/A | -42.2% | 0.00% |
| Sionna Therapeutics, Inc. Common Stock (SION) | $150.63M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Protara Therapeutics Inc (TARA) | $155.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| OnKure Therapeutics, Inc. (OKUR) | $108.33M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $119.05M | N/A | 25.4x | 0.0% | -81.8% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Zura Bio Limited Class A Ordinary Shares, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| TuHURA Biosciences Inc (HURA) | TuHURA Biosciences Inc is a pioneering biotechnology firm committed to advancing immunotherapy solutions for cancer and autoimmune diseases. | HURA competitors |
| LENZ Therapeutics Inc (LENZ) | LENZ Therapeutics Inc is a cutting-edge biopharmaceutical company dedicated to developing transformative therapies for neurological disorders... | LENZ competitors |
| Rallybio Corp (RLYB) | Rallybio Corp is a clinical-stage biotechnology company focused on developing innovative therapies for rare diseases... | RLYB competitors |
| Zentalis Pharmaceuticals Llc (ZNTL) | Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapies for the treatment... | ZNTL competitors |
| Unicycive Therapeutics Inc (UNCY) | Unicycive Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on pioneering therapies for kidney diseases... | UNCY competitors |
| Tiziana Life Sciences Ltd (TLSA) | Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat... | |
| Kazia Therapeutics Ltd ADR (KZIA) | Kazia Therapeutics Limited, a biotechnology company focused on oncology, develops anticancer drugs. The company is headquartered in Sydney, Australia. | |
| Sutro Biopharma (STRO) | Sutro Biopharma, Inc. is a clinical stage drug discovery, development and manufacturing company. | STRO competitors |
| Upstream Bio, Inc. (UPB) | Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. | UPB competitors |
| Sionna Therapeutics, Inc. Common Stock (SION) | Sionna Therapeutics, Inc. is an innovative biotechnology company focused on developing advanced therapies for neurodegenerative disorders... | SION competitors |
| Protara Therapeutics Inc (TARA) | Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to identifying and promoting transformative therapies for the treatment... | TARA competitors |
| OnKure Therapeutics, Inc. (OKUR) | OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. | OKUR competitors |
Frequently Asked Questions About ZURA
Who are Zura Bio Limited Class A Ordinary Shares' main competitors?
The companies most similar to Zura Bio Limited Class A Ordinary Shares include TuHURA Biosciences (HURA), LENZ Therapeutics (LENZ), Rallybio (RLYB), Zentalis Pharmaceuticals Llc (ZNTL) and Unicycive Therapeutics (UNCY), listed from the closest match.
Who is Zura Bio Limited Class A Ordinary Shares' biggest competitor?
Zentalis Pharmaceuticals Llc (ZNTL) is the largest of the similar companies at $167.05M; TuHURA Biosciences (HURA) is the closest match by business profile, size, sector and industry.
How does ZURA stock compare with its competitors?
ZURA's net margin is 0.0% against a peer median of 0.0%.
Which of Zura Bio Limited Class A Ordinary Shares' competitors pays a higher dividend?
Zura Bio Limited Class A Ordinary Shares pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Zura Bio Limited Class A Ordinary Shares bigger than its competitors?
No. Zura Bio Limited Class A Ordinary Shares is 7th by market cap among the 13 companies on this page; the largest is Zentalis Pharmaceuticals Llc (ZNTL) at $167.05M.
ZURA pages: Overview, Earnings, Forecast, Financials, Competitors